Christopher A. Seeger - Seeger Weiss LLP

Christopher A. Seeger

Partner

55 Challenger Road, Ridgefield Park, NJ 07660

cseeger@seegerweiss.com

T 973-639-9100

F 973-584-9393

Download vCard

Christopher A. Seeger

Partner

cseeger@seegerweiss.com

T 973-639-9100

F 973-584-9393

On this page

Bio

A founding partner of Seeger Weiss, Chris is widely recognized as a highly innovative and accomplished plaintiff attorney. Chiefly known for multidistrict mass torts and class actions involving drug injury, toxic injury and personal injury, Chris’s versatile practice also includes product liability, property damage, antitrust, third-party payer litigation, as well as consumer, insurance, and securities fraud.

Chris has led some of the most complex, groundbreaking, and high-profile litigations in the U.S., at both the state and federal level, including In re National Football League Players’ Concussion Injury Litigation, In re Volkswagen “Clean Diesel” Marketing, Sales Practices and Products Liability Litigation, and In re Syngenta AG MIR 162 Corn Litigation. Often selected by the courts to serve as Lead Counsel, Co-Lead Counsel, Liaison Counsel, or member of the Plaintiffs’ Executive and/or Steering Committee in dozens of proceedings, Chris received the most multidistrict litigation (MDL) appointments of any lawyer between 2016 and 2019 according to a 2020 ALM study. More recently, he has served on the Plaintiffs’ Executive Committee in In re: National Prescription Opiate Litigation, and co-lead counsel in In re 3M Combat Arms Earplug Products Liability Litigation, In re Proton-Pump Inhibitor Products Liability Litigation, In re Philips Recalled CPAP, Bi-Level Pap, and Mechanical Ventilator Products Litigation, and In re: Social Media Adolescent Addiction/Personal Injury Products Liability Litigation. His unique experience makes him a knowledgeable and capable litigator and highly regarded among his colleagues.

Chris is regularly quoted in the press as the plaintiff counsel in nationally and internationally prominent cases, including the New York Times, Wall Street Journal, Chicago Tribune, Los Angeles Times, Bloomberg, CBS, CNBC, USA Today, ESPN, and HBO Sports.

Chris started his career as a corporate defense lawyer representing the interests of big business. Struck by the imbalance of power between corporations and the individuals harmed by them, he left to become a plaintiff attorney. The son of a union carpenter who worked his way through school, Chris is a former amateur boxer and a current Brazilian Jiu Jitsu black belt. Now, whether working on a class action involving thousands of people against a multinational conglomerate or an individual case protecting one client’s rights, he fights with the same passion and conviction.

Education

1990, Juris Doctor, magna cum laude
Benjamin N. Cardozo School of Law

1987, Bachelor of Arts, summa cum laude
Hunter College of the City University of New York

Practices

Catastrophic & Serious Injury Lawsuits Environmental Litigation Whistleblower Claims Product Liability

Admissions

States

New Jersey, 1990
New York, 1991

District Courts

District of Colorado, 2011
Eastern District of Michigan, 2017
Eastern District of New York, 2002
Southern District of New York, 1992
Northern District of New York, 2020
District of New Jersey, 1991

Courts of Appeals

Second Circuit, 2010
Third Circuit, 2014
Sixth Circuit, 2019
Ninth Circuit, 2009
Tenth Circuit, 2018

Memberships & Associations

American Bar Association

The Association of the Bar of the City of New York

New Jersey State Bar Association

New York State Trial Lawyers Association

International Society of Barristers

American Bar Foundation

American Association for Justice

Trial Lawyers for Public Justice

Elected Member, American Law Institute

Advisory Board, RAND Center for Catastrophic Risk Management and Compensation

Advisory Board, Center on Civil Justice at New York University School of Law

Advisory Council, Duke Law Center for Judicial Studies

Dean’s Advisory Counsel, Benjamin N. Cardozo School of Law

Board of Trustees, Hunter College Foundation

Pre-Law Advisory Board, Hunter College

Co-General Counsel, Badge of Honor Memorial Foundation, 2008–present

Selected Representation

Product Liability

Philips CPAP, Bi-Level Pap, & Mechanical Ventilator Litigation

Open, accepting new clients

Appointed Co-lead Counsel in MDL prosecuting claims related to the disintegration or outgassing of foam in Philips CPAP sleep apnea machines and other Philips assisted breathing devices.

Product Liability

3M Combat Arms Earplug Products Liability Litigation

Open, accepting new clients

Prior results do not guarantee or predict a similar outcome in any future matter.

Appointed Co‐lead Counsel in MDL prosecuting product liability claims arising from product. Involved in the trial team for the third of three initial bellwether trials, which saw a jury verdict of $1.7 million on behalf of Iraq veteran Lloyd Baker.

Automotive

Volkswagen “Clean Diesel” Marketing, Sales Practices, & Products Liability Litigation

Resolved

Prior results do not guarantee or predict a similar outcome in any future matter.

Appointed to Plaintiffs’ Steering Committee by the Honorable Charles R. Breyer, representing individuals affected by the Volkswagen diesel emissions controversy. Served on the Settlement Committee and was one of the lead negotiators of a $21 billion settlement which includes a massive buyback program for consumers and billions of dollars for environmental remediation.

Catastrophic & Serious Injury Lawsuits

NFL Players’ Concussion Injury Litigation

Resolved

Prior results do not guarantee or predict a similar outcome in any future matter.

Appointed Co-Lead Class Counsel by the Honorable Anita Brody, serving as chief negotiator on behalf of plaintiffs in the highly visible and contentious multidistrict litigation against the National Football League. There, Chris faced significant legal and procedural challenges, including those associated with federal preemption, causation and sub-classing. Ultimately, he was able to surmount these hurdles and lead settlement negotiations under the auspices of a mediator, and in coordination with subclass counsel. The results achieved there—an uncapped settlement fund valued at approximately $1 billion and a medical testing program—were overwhelmingly supported by the class and received unprecedented media attention. This settlement was approved by the Third Circuit Court of Appeals and certification of appeal was recently denied by the United States Supreme Court.

Commercial Litigation

Syngenta AG MIR 162 Corn Litigation

Resolved

Prior results do not guarantee or predict a similar outcome in any future matter.

Appointed to the Plaintiffs’ Settlement Negotiating Committee by the Honorable John W. Lungstrum, serving as one of the principal negotiators in representing nationwide corn producers harmed as a result of Swiss agrochemical giant Syngenta AG’s premature commercialization of genetically modified strains of corn known as Agrisure Viptera and Duracade. A federal jury verdict of $217.7 million in compensatory damages in a Kansas class-wide trial led to the announcement in December 2018 of a nationwide settlement of $1.5 billion.

Drug Injury

Testosterone Replacement Therapy Products Liability Litigation

Resolved

Prior results do not guarantee or predict a similar outcome in any future matter.

Appointed Co-Lead Counsel by the Honorable Matthew Kennelly, representing the interests of individuals who were injured by testosterone medications.

Drug Injury

National Prescription Opioid Litigation

Open, not accepting clients

Appointed to the Executive and Settlement Committees by the Hon. Dan A. Polster, leading numerous lawsuits, many filed by local governments, against pharmaceutical manufacturers and distributers over the alleged improper and misleading marketing and widespread diversion of prescription painkillers into states, counties and cities across the nation, leading to the current opioid addiction crisis.

Intel Multithreading Chip & Server Lawsuit

Product Liability

Intel Corp. CPU Marketing, Sales Practices & Products Liability Litigation

Open, not accepting clients

Appointed Interim Co-Lead Counsel in the nationwide lawsuit against Intel Corp., prosecuting fraud, product defect, and related claims on behalf of consumers who purchased computers and other devices containing flawed computer chips.

Drug Injury

Fresenius Granuflo/Naturalyte Dialysate Products Liability Litigation

Open, not accepting clients

Appointed to the Plaintiffs’ Executive Committee by the Honorable Douglas P. Woodlock.

Drug Injury

Zyprexa Products Liability Litigation

Resolved

Prior results do not guarantee or predict a similar outcome in any future matter.

Appointed as Liaison Counsel by the Honorable Jack B. Weinstein, serving as one of the chief negotiators in connection with a national $700 million settlement with Eli Lilly for over 8,000 claims that Zyprexa caused diabetes-related injuries. This was followed by a $500 million second-round settlement. Chris was the first to conceive of and use a global lien resolution administrator in the class or mass action context to resolve government and/or third-party liens, resulting in significant savings and quicker payments to class members.

Product Liability

Depuy Orthopaedics, Inc. ASR Hip Implant Products Multidistrict Litigation

Open, not accepting clients

Appointed to the Plaintiffs’ Executive Committee by the Honorable David A. Katz, involved in negotiating an almost $3 billion settlement.

Drug Injury

Yasmin and YAZ Marketing, Sales Practices and Products Liability Litigation

Resolved

Prior results do not guarantee or predict a similar outcome in any future matter.

Appointed to the Plaintiffs’ Steering Committee by the Honorable David R. Herndon. Was the first to settle own clients’ cases, which ultimately led to the creation of nationwide settlement program exceeding $2 billion.

Drug Injury

Vioxx Products Liability Litigation

Resolved

Prior results do not guarantee or predict a similar outcome in any future matter.

Unanimously selected by the plaintiffs’ lawyers as Co-Lead Counsel and appointed by the Honorable Eldon E. Fallo. Developed the overall litigation strategy for the approximately 27,000 separate cases against Merck & Co., securing a settlement for $4.85 billion following five years of intense litigation, but mere months after obtaining a jury verdict of $47.5 million in a client’s bellwether trial (Humeston v. Merck & Co., Inc., case no. ATL-L-2272-03, N.J. Super. Ct. Atlantic County). Conceived and used a global lien resolution administrator, resulting in significant savings and quicker payments to class members.

Product Liability

Chinese‐Manufactured Drywall Products Liability Litigation

Resolved

Prior results do not guarantee or predict a similar outcome in any future matter.

Appointed as Chair of the Plaintiffs’ Trial Committee by the Honorable Eldon E. Fallon in, serving as lead trial counsel in obtaining successful verdicts in a succession of bellwether liability and damages trials on behalf close to 5,000 property owners who used the allegedly toxic drywall, many in rebuilding homes destroyed by Hurricane Katrina. These verdicts served as the precursor to a national settlement valued at approximately $1 billion with worldwide drywall distributor Knauf Plasterboard Tianjin (KPT) in 2011.

Drug Injury

Invokana Products Liability Litigation

Resolved

Prior results do not guarantee or predict a similar outcome in any future matter.

Appointed by the Honorable Brian R. Martinotti as Co-Lead Counsel of the Plaintiffs’ Steering Committee on January 24, 2017, representing plaintiffs against Johnson & Johnson Co. and Janssen Pharmaceuticals, Inc., claiming injuries including diabetic ketoacidosis, acute kidney failure and amputations as a result of taking the drug Invokana.

Drug Injury

Actos (Pioglitazone) Products Liability Litigation

Open, not accepting clients

Appointed by the Honorable Rebecca F. Doherty to the Plaintiffs’ Steering Committee of the consolidated MDL, obtaining a jury verdict of $9 billion in punitive damages, the seventh-largest verdict in US history (later reduced to $36.8 million), against Takeda Pharmaceutical Co., Asia’s largest drug maker, and marketing partner Eli Lilly & Co., on behalf of plaintiffs who developed bladder cancer resulting from their Actos diabetes drug.

Product Liability

Phenylpropanolamine (PPA) Products Liability Litigation

Resolved

Prior results do not guarantee or predict a similar outcome in any future matter.

Served as principal negotiator and Co-Lead Counsel in the nationwide settlement of all PPA (phenylpropanolamine)-related injuries resulting from the ingestion of weight loss product Dexatrim. Was involved in the litigation against numerous other manufacturers of pharmaceuticals containing PPA, serving on the MDL Plaintiffs’ Steering Committee in the Western District of Washington and as Liaison Counsel in the New York state court litigation. Plaintiffs were awarded over $40 million.

No aspect of this or any advertisement has been approved by the Supreme Court of New Jersey or a court or authority of any jurisdiction.

Chambers USA, Tier 1 Nationwide in Product Liability: Plaintiffs, 2020-2023, 2017-2018, 2013

Chris has been listed by Chamber and Partners as ‘Top Ranked’ in the category Product Liability: Plaintiffs 2013, 2017-2019, 2020-2023 Chambers USA, Tier 1 Nationwide. The Chambers selection methodology can be found here. No aspect of this advertisement has been approved by the Supreme Court of New Jersey.

Learn more about their selection methodology

National Law Journal's Elite Trial Lawyers Lifetime Achievement Award, 2022

Chris was recognized with The National Law Journal’s Elite Trial Lawyers Lifetime Achievement Award in 2022. The award honors Chris for the indelible mark he has left on his community, clients, and practice throughout his accomplished career in the plaintiffs’ bar. No aspect of this advertisement has been approved by the Supreme Court of New Jersey.

Learn more about their selection methodology

National Law Journal, Plaintiffs’ Lawyer Trailblazers, 2021

Chris was recognized by The National Law Journal in 2021 as Plaintiffs’ Lawyer Trailblazers.

Elite Boutique Trailblazer, National Law Journal, 2018

Chris was recognized by The National Law Journal in 2018 as Elite Boutique Trailblazer.

Top 50 Litigation Trailblazers and Pioneers, National Law Journal, 2014

Chris was recognized by The National Law Journal in 2014 as Top 50 Litigation Trailblazers and Pioneers. According to the editors of The National Law Journal, Chris has

“Changed the practice of litigation through the use of innovative legal strategies.”

Each year, The National Law Journal features several Trailblazer issues and accepts nominees from readers for who they believe made an impact in their respective practice areas. The publication’s editor reviews the nominees and selects 20 to 25 nominees for each practice area. The National Law Journal is issued by ALM. No aspect of this advertisement has been approved by the Supreme Court of New Jersey.

Learn more about their selection methodology

Top Product Liability Verdicts of 2015-2019, National Law Journal, 2020

Chris was included in The National Law Journal’s Top Product Liability Verdicts of 2015-2019. The National Law Journal is issued by ALM. A description of the selection methodology can be found here. No aspect of this advertisement has been approved by the Supreme Court of New Jersey.

Learn more about their selection methodology

Nation’s Top One Percent, National Association of Distinguished Counsel, 2015-2023

Chris was recognized as Nation’s Top One Percent by the National Association of Distinguished Counsel, 2015-2023. The NADC selection methodology can be found here. No aspect of this advertisement has been approved by the Supreme Court of New Jersey.

Learn more about their selection methodology

Lawdragon 500 Leading Lawyers in America, 2007–2023

Lawdragon Legends – 50 lawyers who made the Lawdragon 500 list 10 consecutive years, 2015

Chris has been selected for inclusion on Lawdragon’s 2007-2023 list of 500 Leading Lawyers. This guide, first published in 2007 by Lawdragon Inc., presents Lawdragon’s opinion of “the best of the U.S. plaintiff bar who specialize in representing individual investors and shareholders, as well as businesses and other organizations harmed by corporate misconduct or other failures.” No aspect of this advertisement has been approved by the Supreme Court of New Jersey.

Learn more about their selection methodology

2023 Lawdragon 500 Plaintiff Consumer Lawyers

Lawdragon 500 Leading Plaintiff Consumer Lawyers, 2019-2023

Chris has been selected for inclusion on Lawdragon’s list of 500 Leading Plaintiff Consumer Lawyers every year from 2019 through 2023. This guide, first published in 2007 by Lawdragon Inc., presents Lawdragon’s opinion of “the best of the U.S. plaintiff bar who specialize in representing individuals who have suffered injuries from accidents, pharmaceuticals, civil rights abuse and other torts.” No aspect of this advertisement has been approved by the Supreme Court of New Jersey.

Learn more about their selection methodology

Lawdragon 500 Leading Plaintiff Financial Lawyers, 2019-2023

Chris has been selected for inclusion on Lawdragon’s 2019-2022 list of 500 Leading Plaintiff Financial Lawyers. This guide, first published in 2007 by Lawdragon Inc., presents Lawdragon’s opinion of “the best of the U.S. plaintiff bar who specialize in representing individual investors and shareholders, as well as businesses and other organizations harmed by corporate misconduct or other failures.” Lawdragon’s selection methodology is based on a combination of objective criteria including research of top verdicts and settlements, peer recognition, and interviews with lawyers throughout the country. No aspect of this advertisement has been approved by the Supreme Court of New Jersey.

Learn more about their selection methodology

Lawdragon 500: The Legends, 2016

Chris was selected as a Lawdragon 500 Legend in 2016 for being recognized in a Lawdragon guide over 10 times since their founding in 2005. First published in 2015, Lawdragon considers The Legends to be “a dazzling array of law firm leaders, plaintiff icons, Supreme Court justices, corporate counsel and public interest attorneys.” Lawdragon’s selection methodology is based on a combination of objective criteria including research of top verdicts and settlements, peer recognition, and interviews with lawyers throughout the country. No aspect of this advertisement has been approved by the Supreme Court of New Jersey.

Learn more about their selection methodology

Best Lawyers' Lawyer of the Year, 2021

Chris was selected as 2021 Lawyer of the Year by Best Lawyers, in the category of Mass Tort Litigation / Class Actions – Plaintiffs. Best Lawyers is issued by U.S. News & World Report L.P. The Best Lawyers selection methodology can be found here. No aspect of this advertisement has been approved by the Supreme Court of New Jersey.

Learn more about their selection methodology

Best Lawyers in America: U.S. News & World Report – Mass Tort Litigation / Class Actions - Plaintiffs, 2006-2024

Chris was selected 2006-2024 Best Lawyers in America: U.S. News & World Report – Mass Tort Litigation / Class Actions – Plaintiffs. Best Lawyers is issued by U.S. News & World Report L.P. The Best Lawyers selection methodology can be found here. No aspect of this advertisement has been approved by the Supreme Court of New Jersey.

Learn more about their selection methodology

America’s 50 Most Influential Trial Lawyers, Trial Lawyer Magazine, 2016–2020

Chris was selected America’s 50 Most Influential Trial Lawyers, by Trial Lawyer Magazine in 2016-2020. America’s 50 Most Influential Trial Lawyers list is issued by Legal Associations Management, Inc. A description of the selection methodology can be found here. No aspect of this advertisement has been approved by the Supreme Court of New Jersey.

Learn more about their selection methodology

The Trial Lawyer RoundTable - America's Most Influential Trial Lawyers

America’s 50 Most Influential Trial Lawyers, Trial Lawyer Magazine, 2016–2020

Chris was recognized by the Trial Lawyer RoundTable in 2016 as Top 50 Most Influential Trial Lawyers. The Trial Lawyer RoundTable selection methodology can be found here. No aspect of this advertisement has been approved by the Supreme Court of New Jersey.

Learn more about their selection methodology

Product Liability Titans of the Plaintiffs Bar, Law360, 2018

Chris was selected to Law360’s Product Liability Titans of the Plaintiffs Bar in 2018. Product Liability Titans of the Plaintiffs Bar list is issued by Portfolio Media, Inc. A description of the selection methodology can be found here. No aspect of this advertisement has been approved by the Supreme Court of New Jersey.

Learn more about their selection methodology

New Jersey/New York Super Lawyers, 2006-2023

Chris was selected to both the New York Super Lawyers list and the New Jersey Super Lawyers list from 2006 through 2023. The Super Lawyers list is issued by Thomson Reuters. A description of the selection methodology can be found here. No aspect of this advertisement has been approved by the Supreme Court of New Jersey.

Learn more about their selection methodology

The American Lawyer's Litigation Daily "Litigator of the Week"

Chris Seeger was selected as The American Lawyer’s Litigation Daily “Litigators of the Week” for his work on the proposed $26 billion opioid settlement. No aspect of this advertisement has been approved by the Supreme Court of New Jersey.

Learn more about their selection methodology

Legal 500: Hall of Fame, 2023

Chris was selected to Legal 500’s Hall of Fame in 2023. The list “highlights individuals who have received constant praise from their clients for continued excellence” and those “who are at the pinnacle of the profession.” The Legal 500 list is issued by Legalease Ltd. A description of the selection methodology can be found here. No aspect of this advertisement has been approved by the Supreme Court of New Jersey.

Learn more about their selection methodology

Legal 500, 2010-2020

Chris has been selected to the Legal 500 Series 2010-2020. The Legal 500 list is issued by Legalease Ltd. A description of the selection methodology can be found here. No aspect of this advertisement has been approved by the Supreme Court of New Jersey.

Chris was described by the editors of Legal 500 United States as:

“A renowned trial lawyer.”

“A determined trial lawyer.”

“Highly regarded.”

Learn more about their selection methodology

Martindale-Hubbell AV Preeminent, 2012–2020

Chris was rated as AV Preeminent five stars by Martindale-Hubbell from 2012-2020. No aspect of this advertisement has been approved by the Supreme Court of New Jersey.

Learn more about their selection methodology

Top 20 Personal Injury Awards of the Year, New Jersey Law Journal, 2007

Chris was recognized by the New Jersey Law Journal on the list of Top 20 Personal Injury Awards of the Year, 2007. The New Jersey Law Journal is published by ALM Media Properties, LLC. No aspect of this advertisement has been approved by the Supreme Court of New Jersey.

Hunter College Distinguished Alumni Lawyer Award, 2013

Cardozo Law Alumnus of the Year Award, 2009

Hunter College Alumni Hall of Fame, 2007

National Trial Lawyers: Top 100 Trial Lawyers

Chris was recognized by the National Trial Lawyers on the list of Top 100 Trial Lawyers. According to the editor of National Trial Lawyers, Chris is:

“One of the nation’s most versatile, respected and accomplished attorneys in cases related to drug and toxic injury, as well as in the area of personal injury litigation.”

“Mr. Seeger has served as lead attorney and in other significant leadership roles in many of the country’s most newsworthy and groundbreaking federal and state actions involving consumer fraud and negligence.”

“Mr. Seeger approaches each case with compassion, knowing that each plaintiff, whether as an individual or as part of a large group, has suffered immensely and needs an effective partner to get through what is inevitably a difficult and emotional time. His success in the courtroom and at the settlement table have helped many injured people recover financial awards.”

The National Trial Lawyers selection methodology can be found here. No aspect of this advertisement has been approved by the Supreme Court of New Jersey.

Learn more about their selection methodology

Scholarship & Leadership

Presenter, Trial Lawyers of Mass Torts: Settlement and Resolution, March 2023

Presenter, “Settlement and Resolution,” Mass Tort MDL Certificate Program, Bolch Judicial Institute, Duke Law, November 8, 2022

Presenter, “Future of Trial Practice,” The Future of Trial Practice in Pharmaceutical Drug and Device Litigation, American Bar Association, June 23, 2022

Presenter, “Settlement and Resolution,” Advanced MDL Certificate, Bolch Judicial Institute, Duke Law, May 26, 2022

Presenter, “Best Practices in Resolution and the Search for Closure,” Contemporary Issues in Complex Litigation, Northwestern Pritzker School of Law, April 7, 2022

Presenter, “The Centralization Process,” Mass-Tort MDL Certificate Program, Bolch Judicial Institute, Duke Law, November 15, 2021

Presenter, “Settlement,” Mass-Tort MDL Certificate Program, Bolch Judicial Institute, Duke Law, November 17, 2021

Presenter, “The Mechanics and Motivations of Settlements, Especially with Public Entities,” Symposium on Novel Liability Theories and the Incentives Driving Them, George Mason University Antonin Scalia Law School, October 26, 2021

Presenter, “Best Practices in Resolution and the Search for Closure”, Contemporary Issues in Complex Litigation Conference, Northwestern University Pritzker School of Law, April 7, 2022

Member, leadership council, Bolch Judicial Institute, Duke Law

Adjunct professor, Trial Advocacy and Complex Litigation, Benjamin N. Cardozo School of Law

Presenter, “Global Settlements in Today’s Mass Tort Litigation,” Mass Tort Litigation Conference, Perrin Conferences, Thursday, June 24, 2021

Presenter, “Class-Action Challenges,” Class Action Case Law and Practices Review Bench-Bar Conference, James F. Humphreys Complex Litigation Center, George Washington University School of Law, November 13, 2020

Presenter, “Are MDL Judges Too Powerful?”, The Federalist Society, November 10, 2020

Adjunct professor, “Initial Stages and the JPML” & “Settlement,” Mass-Tort MDL Certificate Program, Bolch Judicial Institute, Duke Law, November 9, 2020

Presenter, “Opioid Litigation: What’s New, and What Does It Mean for Future Litigation?”, RAND Institute for Civil Justice, October 22, 2020

Presenter, “MDLs & Class Actions: A Discussion with Chris Seeger and Elizabeth Burch,” Center on Civil Justice, NYU School of Law, October 20, 2020

Presenter, “The Role of the Trial in Modern Complex Litigation,” Northwestern Pritzker School of Law, November 28, 2018

Presenter, “The ABCs of Settling Mass Torts,” ABA Current Issues in Pharmaceutical, Medical Device, and Biotech Litigation Regional CLE Program, November 9, 2018

Presenter, “Third Party Litigation Finance of Attorneys in Traditional and Complex Litigation,” George Washington University Law School, November 2, 2018

Presenter, “NFL Players’ Concussion Injury Litigation,” 2018 Transferee Judges’ Conference, October 30, 2018

Presenter, “The NFL Concussion Litigation: The Impact of Traumatic Brain Injury on America’s Most Popular Sport,” Fordham Law School, October 17, 2018

Presenter, “Theory of Aggregation: Class Actions, MDLs, Bankruptcies, and More,” NYU School of Law, October 12, 2018

Presenter, “FBA: Perspectives on Class Action and Multi District Litigation,” 2018 FBA Annual Meeting & Convention, September 13, 2018

Presenter, “Impact of Critical Transferee Judge Decisions Not Subject to Review or Appeal,” Duke University School of Law, April 26, 2018

Presenter, “How Does it End – Settlement, Trial, or Remand,” Federal Judicial Center, March 15, 2018

Presenter, Bolch Judicial Institute, Duke University School of Law, March 13, 2018

Presenter, “NFL Concussion Case Study,” Columbia Law School, March 2, 2018

Presenter, “Current Issues in the Trial of Complex Matters,” Northwestern Pritzker School of Law, November 30, 2017

Presenter, “Mass Tort Trends – 1,000 Claimants to 100 Million,” Mass Tort Global Settlement Architecture Conference, October 27, 2017

Presenter, “Trying Cases and Settlement,” Federalist Society, October 19, 2017

Presenter, Emory Law School Bridge Program, September 14, 2017

Presenter, “The Aggregation of Claims: Pros and Cons,” RAND Institute for Civil Justice, May 19, 2017

Presenter, “Limits on Judicial Participation in and Approval of Non-Class Settlements,” George Washington University Law School, April 27, 2017

Presenter, “Case Management Techniques: What Helps, What Backfires, and How to Get to Efficient Resolution,” Emory Law Institute for Complex Litigation and Mass Claims, December 14, 2016

Presenter, “There’s No Place like Home: The Pros and Cons of Lexecon Waivers and Bellwether Trials in the Modern MDL,” American Bar Association Continuing Legal Education Workshop, November 4, 2016

Presenter, “Bellwether Trials? Purpose, Including Whether to Eliminate Them Altogether, Selection, and Early Dismissal,” Duke Law Center for Judicial Studies, October 28, 2016

Presenter, “NFL: The challenges and rewards of serving as lead counsel in one of the most highly publicized class actions in history,” Oregon Law Institute of Lewis & Clark Law School, February 16, 2016

Presenter, “Trials & Error: The NFL Concussion Settlement,” NYU School of Law, February 2, 2016

Presenter, “Volkswagen Diesel Emissions Fraud: Arguments for Potential Transfer Venues,” American Association for Justice, December 2, 2015

Presenter, “Common Benefit Funds,” Duke Law Center for Judicial Studies, November 9, 2015

Presenter, “Common Benefit Fund/Attorney Fees,” Duke Law Center for Judicial Studies, May 2, 2013

Managing Editor, Cardozo Law Review, 1990

↑

Bio

Education

Practices

Admissions

Memberships & Associations

Selected Representation

Community Involvement

Scholarship & Leadership